A pattern ST sees increasingly often
Among patients arriving for under-eye fat repositioning, one group appears increasingly often: people who first had a collagen-stimulating injection under the eyes. These are products — sold under many brand names, from several countries — whose active ingredient is not a filler that occupies space but a substance that provokes the skin to produce its own collagen. They are widely marketed as a safe, non-surgical option, and the story behind most of these patients is the same. Surgery felt frightening, an injection did not, so they tried the injection first, were not satisfied, and eventually came to consider surgery anyway. By then the injection has changed the tissue the surgeon has to work with. ST's position, stated plainly: ST advises against collagen-stimulating injections under the eyes. The rest of this article explains why the under-eye is the one place where this class of product behaves differently, and what to do instead if you are not ready for surgery.
Why the under-eye is not like the rest of the face
In most of the face, the skin sits on a substantial layer of subcutaneous fat, and below that the muscle. There is room. A collagen stimulator placed in the forehead or the cheek is surrounded by thick tissue, and moderate collagen production there can genuinely improve firmness. The lower eyelid is built differently. The skin is the thinnest on the face, the subcutaneous fat beneath it is almost a film, and the muscle comes immediately after. The deeper orbital fat — the fat that forms the bag — sits behind a separate membrane and is not the layer these injections reach. In practical terms the skin, the thin fat, and the muscle of the under-eye together are close to a single shell. There is no buffer layer in which extra collagen can form without involving the skin and the muscle at the same time.
How collagen stimulation turns into fibrosis
Collagen is what the body uses to heal a wound. Anyone who has had a burn or a deep scrape knows what happens when the body makes too much of it: the scar rises, hardens, becomes uneven, itches. That is over-produced collagen. In the right amount, new collagen improves elasticity; in excess, it changes the character of the skin itself. When a stimulating agent is injected into the shallow under-eye layer, the collagen that forms binds the skin down toward the muscle. The tissue stiffens, and a boundary appears between the injected area and the untreated skin around it — a boundary that becomes most obvious when the face moves, especially when smiling. This is fibrosis. Small, conservative amounts sometimes cause no trouble, and ST does see patients whose skin tolerated it. But most of these products are placed the way a skin booster is placed, spread broadly beneath the whole under-eye, so the total dose is large and the odds of over-production rise with it.
What it means when you later want surgery
In ST's clinical experience of operating on patients who had these injections beforehand — an observation, not a formal study — roughly a third do well without any special measures — their skin stayed supple and no boundary is visible. For the majority, a good result requires first removing the fibrotic tissue during surgery, which adds time, dissection, and uncertainty. An analogy ST uses at consultation: repositioning rebuilds the shape underneath — the body, if you like — but the skin is the garment over it, and the garment has to be smooth for the shape to show. Skin that has fibrosed after a stimulator is no longer one continuous fabric; it is a soft T-shirt on one part and heavy denim on another, and the seam between them shows. Removing the fibrosis turns the denim into something closer to trousers. It does not turn it back into a dress. The other unwelcome fact is duration. The product itself is metabolised, but the collagen it provoked is tissue, not product. Like a scar, it can persist for two, three, five years, and in some people indefinitely.
If you are not ready for surgery, what ST recommends instead
ST is not against non-surgical treatment of the under-eye. The objection is to one specific category: anything that permanently changes the structure of the skin in this thin, sensitive area. If you want an injectable while you decide about surgery, a dissolvable hyaluronic-acid filler is the safer choice. It is not risk-free: like any injection near the eye it carries rare but serious risks, including vascular occlusion, and should only be done by an experienced injector. It is not without other limits — it can look bluish in thin skin and it does not correct the tear-trough tether — but its defining advantage is that it is reversible: it fades with time, and if it causes a problem before then, a dissolving enzyme removes it. Laser treatments and skin-surface procedures are also acceptable. The principle is simple. In other areas of the face, use your judgement. Under the eyes, avoid products whose entire purpose is to make the tissue produce collagen it will not later give back.
If you have already had them: what to tell the surgeon
Having had a stimulator does not rule out surgery. It changes the plan, and the plan can only be right if the surgeon knows. Bring the name of the product if you have it, the approximate amount, the number of sessions, and the dates — even a rough timeline helps, because more recent and higher-volume treatment is more likely to have produced significant fibrosis. The surgeon will examine how the skin moves over the muscle, whether a boundary is visible on animation, and how much of the under-eye is involved. From that, the operation may include removing fibrotic tissue before the fat is repositioned, and the expectations for surface smoothness are adjusted honestly. What does not work is leaving the history out and hoping it does not matter. It matters to the length of the surgery, to the result, and to the safety of the tissue.